Resolvin E1 and its precursor 18R-HEPE restore mitochondrial function in inflammation

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Inflammatory disorders, including sepsis, significantly contribute to illness and death.
• Mitochondrial dysfunction is a critical factor in severe inflammatory disease development.
• Omega-3 (n-3) fatty acids and their derivatives are being explored for therapeutic benefits.

Purpose of the Study:

• To investigate the effects of arachidonic acid, n-3 fatty acids, 18R-HEPE, and resolvin E1 (RvE1) on mitochondrial function during experimental inflammation.
• To elucidate the mechanisms by which these lipid mediators influence mitochondrial dynamics and inflammatory responses.

Main Methods:

• Experimental inflammation model.
• Assessment of mitochondrial respiration and membrane potential.
• Analysis of mitochondrial fission and fusion dynamics.
• Measurement of pro-inflammatory cytokine levels (IL-6, IL-8).
• Inhibition of mitochondrial fission using Mdivi-1 and Dynasore.

Main Results:

• 18R-HEPE and RvE1 demonstrated anti-inflammatory and anti-apoptotic effects, unlike n-6 and n-3 fatty acids.
• These mediators reversed inflammation-induced mitochondrial dysfunction, including impaired respiration and membrane potential.
• RvE1 and 18R-HEPE restored the balance of mitochondrial fission and fusion.
• Inhibiting mitochondrial fission reduced levels of IL-6 and IL-8.

Conclusions:

• Resolvin E1 (RvE1) and 18R-HEPE possess significant anti-inflammatory properties by targeting mitochondrial dysfunction.
• These lipid mediators can restore mitochondrial health and balance fission-fusion dynamics during inflammation.
• Targeting mitochondrial fission represents a novel therapeutic strategy for managing inflammatory conditions like sepsis.